Stem cell transplantation after alemtuzumab in T‐cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2010-06, Vol.149 (6), p.907-910
Hauptverfasser:	Krishnan, Biju, Else, Monica, Tjonnfjord, Geir E., Cazin, Bruno, Carney, Dennis, Carter, John, Ketterer, Nicolas, Catovsky, Daniel, Ethell, Mark, Matutes, Estella, Dearden, Claire E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Alemtuzumab allograft Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Antibodies, Neoplasm - therapeutic use Antineoplastic Agents - therapeutic use autograft Biological and medical sciences Combined Modality Therapy Female Hematologic and hematopoietic diseases Hematopoietic Stem Cell Transplantation - methods Humans Leukemia, Prolymphocytic, T-Cell - therapy Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical sciences Middle Aged Retrospective Studies stem cell transplantation Survival Analysis Treatment Outcome T‐cell prolymphocytic leukaemia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!